Zoledronic acid prevents bone loss in premenopausal women with early breast cancer undergoing adjuvant chemotherapy: A phase III trial of the Korean Cancer Study Group (KCSG-BR06-01).
Phase of Trial: Phase III
Latest Information Update: 23 Mar 2011
At a glance
- Drugs Zoledronic acid (Primary) ; Cyclophosphamide; Doxorubicin; Taxanes
- Indications Early breast cancer; Osteoporosis
- Focus Therapeutic Use
- 23 Mar 2011 New trial record